Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
We utilise our cutting-edge, exclusive workflow to develop focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The procedure entails thorough molecular simulations of the catalytic and allosteric binding pockets, accompanied by ensemble virtual screening that factors in their conformational flexibility. When developing modulators, the structural modifications brought about by reaction intermediates are factored in to optimize activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
Q8WTX9
UPID:
ZDHC1_HUMAN
Alternative names:
DHHC domain-containing cysteine-rich protein 1; Zinc finger DHHC domain-containing protein 1; Zinc finger protein 377
Alternative UPACC:
Q8WTX9; O15461
Background:
Palmitoyltransferase ZDHHC1, also known as DHHC domain-containing cysteine-rich protein 1, plays a crucial role in cellular processes by catalyzing the addition of palmitate onto various protein substrates. This enzyme's activity towards NCDN is significant for regulating its association with endosome membranes through palmitoylation. Beyond its enzymatic functions, ZDHHC1 is pivotal in DNA virus-triggered and CGAS-mediated innate immune responses, acting as an activator of STING1 by promoting its cGAMP-induced oligomerization.
Therapeutic significance:
Understanding the role of Palmitoyltransferase ZDHHC1 could open doors to potential therapeutic strategies.